<HashMap><database>biostudies-other</database><scores/><additional><omics_type>Unknown</omics_type><submitter/><funding>Dutch Research Agenda (NWA)</funding><species>Homo sapiens</species><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-VHPS25</full_dataset_link><repository>biostudies-other</repository></additional><is_claimable>false</is_claimable><name>Tacrolimus-induced nephrotoxicity in tubuloids</name><description>Tacrolimus (TAC) is a first-line immunosuppressant used to prevent rejection after solid-organ transplantation, yet its clinical utility is limited by nephrotoxicity, which can progress to irreversible kidney injury or graft loss. The molecular mechanisms underlying TAC-induced nephrotoxicity remain insufficiently understood. Here, we systematically assessed TAC responses in a human in vitro nephron model: adult stem cell-derived kidney tubuloids from two donors (T19 and T30). Cell viability (CellTiter-Fluor), intracellular tacrolimus accumulation (LC-MS/MS), targeted gene expression of drug transporters and metabolizing enzymes (RT-qPCR) and whole-transcriptome responses (bulk RNA-seq) were measured, with co-treatment by P-glycoprotein (P-gp) inhibitors used to modulate intracellular tacrolimus levels.</description><dates><release>2026-03-18T00:00:00Z</release><modification>2026-06-16T18:30:30.064Z</modification><creation>2026-03-18T11:02:12.422Z</creation></dates><accession>S-VHPS25</accession><cross_references/></HashMap>